Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51


A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.

Balasenthil S, Huang Y, Liu S, Marsh T, Chen J, Stass SA, KuKuruga D, Brand R, Chen N, Frazier ML, Jack Lee J, Srivastava S, Sen S, McNeill Killary A.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw341.


Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.

Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, Srivastava S, Frazier ML, Sen S, Hollingsworth MA, Rinaudo JA, Killary AM, Brand RE.

PLoS One. 2015 Oct 2;10(10):e0139049. doi: 10.1371/journal.pone.0139049. eCollection 2015.


DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity.

Chen N, Balasenthil S, Reuther J, Killary AM.

Cancer Res. 2014 Oct 15;74(20):5683-9. doi: 10.1158/0008-5472.CAN-14-1171. Epub 2014 Sep 26. Review.


Metastasis-associated protein 1 is an integral component of the circadian molecular machinery.

Li DQ, Pakala SB, Reddy SD, Peng S, Balasenthil S, Deng CX, Lee CC, Rea MA, Kumar R.

Nat Commun. 2013;4:2545. doi: 10.1038/ncomms3545.


DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.

Chen N, Balasenthil S, Reuther J, Frayna A, Wang Y, Chandler DS, Abruzzo LV, Rashid A, Rodriguez J, Lozano G, Cao Y, Lokken E, Chen J, Frazier ML, Sahin AA, Wistuba II, Sen S, Lott ST, Killary AM.

Cancer Discov. 2013 Oct;3(10):1172-89. doi: 10.1158/2159-8290.CD-12-0499. Epub 2013 Jul 9.


A migration signature and plasma biomarker panel for pancreatic adenocarcinoma.

Balasenthil S, Chen N, Lott ST, Chen J, Carter J, Grizzle WE, Frazier ML, Sen S, Killary AM.

Cancer Prev Res (Phila). 2011 Jan;4(1):137-49. doi: 10.1158/1940-6207.CAPR-10-0025. Epub 2010 Nov 11.


Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells.

Kumar R, Balasenthil S, Pakala SB, Rayala SK, Sahin AA, Ohshiro K.

Cancer Res. 2010 Aug 15;70(16):6598-608. doi: 10.1158/0008-5472.CAN-10-0907.


Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressor.

Kumar R, Balasenthil S, Manavathi B, Rayala SK, Pakala SB.

Cancer Res. 2010 Aug 15;70(16):6649-58. doi: 10.1158/0008-5472.CAN-10-0909. Epub 2010 Aug 3.


DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.

Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, Band V, El-Naggar AK, Frazier ML, Keyomarsi K, Hunt KK, Sen S, Haffty B, Hewitt SM, Krahe R, Killary AM.

PLoS Med. 2009 May 26;6(5):e1000068. doi: 10.1371/journal.pmed.1000068. Epub 2009 May 5.


Role of PELP1/MNAR signaling in ovarian tumorigenesis.

Dimple C, Nair SS, Rajhans R, Pitcheswara PR, Liu J, Balasenthil S, Le XF, Burow ME, Auersperg N, Tekmal RR, Broaddus RR, Vadlamudi RK.

Cancer Res. 2008 Jun 15;68(12):4902-9. doi: 10.1158/0008-5472.CAN-07-5698.


Identification of Pax5 as a target of MTA1 in B-cell lymphomas.

Balasenthil S, Gururaj AE, Talukder AH, Bagheri-Yarmand R, Arrington T, Haas BJ, Braisted JC, Kim I, Lee NH, Kumar R.

Cancer Res. 2007 Aug 1;67(15):7132-8. Erratum in: Cancer Res. 2015 Jun 15;75(12):2580-1.


Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas.

Bagheri-Yarmand R, Balasenthil S, Gururaj AE, Talukder AH, Wang YH, Lee JH, Kim YS, Zhang X, Jones DM, Medeiros LJ, Stephens LC, Liu YJ, Lee N, Kim I, Kumar R.

Cancer Res. 2007 Aug 1;67(15):7062-7. Erratum in: Cancer Res. 2015 Jun 15;75(12):2582-3.


Repression of Six3 by a corepressor regulates rhodopsin expression.

Manavathi B, Peng S, Rayala SK, Talukder AH, Wang MH, Wang RA, Balasenthil S, Agarwal N, Frishman LJ, Kumar R.

Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13128-33. Epub 2007 Jul 31.


Solution structure and antiestrogenic activity of the unique C-terminal, NR-box motif-containing region of MTA1s.

Singh RR, Kaluarachchi K, Chen M, Rayala SK, Balasenthil S, Ma J, Kumar R.

J Biol Chem. 2006 Sep 1;281(35):25612-21. Epub 2006 Jun 27. Erratum in: J Biol Chem. 2013 Sep 20;288(38):27518.


Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas.

Balasenthil S, Broaddus RR, Kumar R.

Hum Pathol. 2006 Jun;37(6):656-61.


MTA1, a transcriptional activator of breast cancer amplified sequence 3.

Gururaj AE, Singh RR, Rayala SK, Holm C, den Hollander P, Zhang H, Balasenthil S, Talukder AH, Landberg G, Kumar R.

Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6670-5. Epub 2006 Apr 14. Erratum in: Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4147-8.


P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation.

Rayala SK, Talukder AH, Balasenthil S, Tharakan R, Barnes CJ, Wang RA, Aldaz CM, Khan S, Kumar R.

Cancer Res. 2006 Feb 1;66(3):1694-701.


Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) interacts with PELP1 and activates MAPK.

Rayala SK, Hollander Pd, Balasenthil S, Molli PR, Bean AJ, Vadlamudi RK, Wang RA, Kumar R.

J Biol Chem. 2006 Feb 17;281(7):4395-403. Epub 2005 Dec 12.


PAK1 hyperactivation is sufficient for mammary gland tumor formation.

Wang RA, Zhang H, Balasenthil S, Medina D, Kumar R.

Oncogene. 2006 May 11;25(20):2931-6.


Functional implications of altered subcellular localization of PELP1 in breast cancer cells.

Vadlamudi RK, Manavathi B, Balasenthil S, Nair SS, Yang Z, Sahin AA, Kumar R.

Cancer Res. 2005 Sep 1;65(17):7724-32.


Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets.

Vadlamudi RK, Balasenthil S, Sahin AA, Kies M, Weber RS, Kumar R, El-Naggar AK.

Hum Pathol. 2005 Jun;36(6):670-5.


Functional regulation of oestrogen receptor pathway by the dynein light chain 1.

Rayala SK, den Hollander P, Balasenthil S, Yang Z, Broaddus RR, Kumar R.

EMBO Rep. 2005 Jun;6(6):538-44. Erratum in: EMBO Rep. 2005 Nov;6(11):1101.


p21-activated kinase 1 regulates microtubule dynamics by phosphorylating tubulin cofactor B.

Vadlamudi RK, Barnes CJ, Rayala S, Li F, Balasenthil S, Marcus S, Goodson HV, Sahin AA, Kumar R.

Mol Cell Biol. 2005 May;25(9):3726-36. Erratum in: Mol Cell Biol. 2013 Mar;33(6):1267.


Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.

Nair SS, Mishra SK, Yang Z, Balasenthil S, Kumar R, Vadlamudi RK.

Cancer Res. 2004 Sep 15;64(18):6416-23.


Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes.

Vadlamudi RK, Bagheri-Yarmand R, Yang Z, Balasenthil S, Nguyen D, Sahin AA, den Hollander P, Kumar R.

Cancer Cell. 2004 Jun;5(6):575-85. Erratum in: Cancer Cell. 2004 Jul;6(1):101. Cancer Cell. 2013 Mar 18;23(3):421-2.


Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.

Balasenthil S, Barnes CJ, Rayala SK, Kumar R.

FEBS Lett. 2004 Jun 4;567(2-3):243-7.


Cloning and functional characterization of PELP1/MNAR promoter.

Mishra SK, Balasenthil S, Nguyen D, Vadlamudi RK.

Gene. 2004 Apr 14;330:115-22.


p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells.

Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, Vadlamudi RK, Kumar R.

J Biol Chem. 2004 Jan 9;279(2):1422-8. Epub 2003 Oct 6.


HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy.

Yang Z, Bagheri-Yarmand R, Balasenthil S, Hortobagyi G, Sahin AA, Barnes CJ, Kumar R.

Clin Cancer Res. 2003 Aug 1;9(8):3198-203.


Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.

Balasenthil S, Vadlamudi RK.

J Biol Chem. 2003 Jun 13;278(24):22119-27. Epub 2003 Apr 7.


MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions.

Talukder AH, Mishra SK, Mandal M, Balasenthil S, Mehta S, Sahin AA, Barnes CJ, Kumar R.

J Biol Chem. 2003 Mar 28;278(13):11676-85. Epub 2003 Jan 13.


Altered cytokeratin expression during chemoprevention of experimental hamster buccal pouch carcinogenesis by garlic.

Balasenthil S, Rao KS, Nagini S.

J Oral Pathol Med. 2002 Mar;31(3):142-6.


Chemopreventive efficacy of lycopene on 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.

Bhuvaneswari V, Velmurugan B, Balasenthil S, Ramachandran CR, Nagini S.

Fitoterapia. 2001 Dec;72(8):865-74.


Prevention of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis by garlic.

Balasenthil S, Ramachandran CR, Nagini S.

Fitoterapia. 2001 Jun;72(5):524-31.


Coffee enhances the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch carcinomas.

Saroja M, Balasenthil S, Ramachandran CR, Nagini S.

Oral Oncol. 2001 Feb;37(2):172-6.


Garlic enhances circulatory antioxidants during 7, 12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.

Balasenthil S, Arivazhagan S, Nagini S.

J Ethnopharmacol. 2000 Oct;72(3):429-33.


Of humans and hamsters: comparative analysis of lipid peroxidation, glutathione, and glutathione-dependent enzymes during oral carcinogenesis.

Balasenthil S, Saroja M, Ramachandran CR, Nagini S.

Br J Oral Maxillofac Surg. 2000 Aug;38(4):267-70.


Chemopreventive potential of neem (Azadirachta indica) on 7,12-dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinogenesis.

Balasenthil S, Arivazhagan S, Ramachandran CR, Ramachandran V, Nagini S.

J Ethnopharmacol. 1999 Nov 1;67(2):189-95.


Effects of garlic on 7,12-Dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.

Balasenthil S, Arivazhagan S, Ramachandran CR, Nagini S.

Cancer Detect Prev. 1999;23(6):534-8.


Supplemental Content

Loading ...
Support Center